Correlation Between Shenzhen Bioeasy and China Reform

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shenzhen Bioeasy and China Reform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Bioeasy and China Reform into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shenzhen Bioeasy Biotechnology and China Reform Health, you can compare the effects of market volatilities on Shenzhen Bioeasy and China Reform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Bioeasy with a short position of China Reform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Bioeasy and China Reform.

Diversification Opportunities for Shenzhen Bioeasy and China Reform

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Shenzhen and China is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Bioeasy Biotechnology and China Reform Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Reform Health and Shenzhen Bioeasy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Bioeasy Biotechnology are associated (or correlated) with China Reform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Reform Health has no effect on the direction of Shenzhen Bioeasy i.e., Shenzhen Bioeasy and China Reform go up and down completely randomly.

Pair Corralation between Shenzhen Bioeasy and China Reform

Assuming the 90 days trading horizon Shenzhen Bioeasy Biotechnology is expected to under-perform the China Reform. In addition to that, Shenzhen Bioeasy is 1.19 times more volatile than China Reform Health. It trades about -0.01 of its total potential returns per unit of risk. China Reform Health is currently generating about 0.0 per unit of volatility. If you would invest  1,185  in China Reform Health on October 16, 2024 and sell it today you would lose (188.00) from holding China Reform Health or give up 15.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Shenzhen Bioeasy Biotechnology  vs.  China Reform Health

 Performance 
       Timeline  
Shenzhen Bioeasy Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shenzhen Bioeasy Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Shenzhen Bioeasy is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
China Reform Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Reform Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Shenzhen Bioeasy and China Reform Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shenzhen Bioeasy and China Reform

The main advantage of trading using opposite Shenzhen Bioeasy and China Reform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Bioeasy position performs unexpectedly, China Reform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Reform will offset losses from the drop in China Reform's long position.
The idea behind Shenzhen Bioeasy Biotechnology and China Reform Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Managers
Screen money managers from public funds and ETFs managed around the world